SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:		3235-0104
Expires:	February 28, 2011
Estimated average burden
hours per response		0.5

1. Name and Address of Reporting Person^*

HEALTHCARE VENTURES VI LP

(Last)

(First)

(Middle)

44 Nassau Street

(Street)

Princeton

08542

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/15/2003

3. Issuer Name and Ticker or Trading Symbol
ADVANCIS PHARMACEUTICAL CORP [ AVNC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Series B Convertible Preferred	^{( 1 )}	^{( 2 )}	Common Stock	783,810	0	D ^{( 3 )}
Series C Convertible Preferred	^{( 1 )}	^{( 2 )}	Common Stock	2,588,322	0	D ^{( 3 )}
Series D Convertible Preferred	^{( 1 )}	^{( 2 )}	Common Stock	3,883,508	0	D ^{( 3 )}
Series E Convertible Preferred	^{( 1 )}	^{( 2 )}	Common Stock	2,869,252	0	D ^{( 3 )}

1. Name and Address of Reporting Person^*

HEALTHCARE VENTURES VI LP

(Last)

(First)

(Middle)

44 Nassau Street

(Street)

Princeton

08542

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

HEALTHCARE PARTNERS VI LP

(Last)

(First)

(Middle)

44 Nassau Street

(Street)

Princeton

08542

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

CAVANAUGH JAMES H

(Last)

(First)

(Middle)

c/o HealthCare Ventures LLC

44 Nassau Street

(Street)

Princeton

08542

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

CROUSE WILLIAM

(Last)

(First)

(Middle)

c/o HealthCare Ventures LLC

44 Nassau Street

(Street)

Princeton

08542

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

LITTLECHILD JOHN W

(Last)

(First)

(Middle)

One Kendall Square

Building 300

(Street)

Cambridge

02139

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

WERNER HAROLD R

(Last)

(First)

(Middle)

c/o HealthCare Ventures LLC

44 Nassau Street

(Street)

Princeton

08542

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

LAWLOR AUGUSTINE

(Last)

(First)

(Middle)

One Kendall Square

Building 300

(Street)

Cambridge

02339

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

MIRAELLI CHRISTOPHER

(Last)

(First)

(Middle)

One Kendall Square

Building 300

(Street)

Cambridge

02339

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

AGUIAR ERIC

(Last)

(First)

(Middle)

C/O HEALTHCARE VENTURES LLC

44 NASSAU STREET

(Street)

PRINCETON

08542

(City)

(State)

(Zip)

Explanation of Responses:

1. Immediately exercisable.

2. Each of these shares will automatically convert into 0.5464242 shares of Common Stock of the Issuer on the date of the Closing of the initial public offering of the Issuer's securities.

3. These securities are owned by HealthCare Ventures VI, L.P. ("HCVVI"). These securities are indirectly owned by HealthCare Partners VI, L.P. ("HCPVI"), the General Partner of HCVVI and each of James Cavanaugh, Harold Werner, William Crouse, John Littlechild, Christopher Mirabelli, Augustine Lawlor and Eric Aguiar, the general partners of HCPVI. Drs. Cavanaugh, Mirabelli and Aguiar, and Messrs. Werner, Crouse, Littlechild and Lawlor disclaim beneficial ownership in those securities in which they do not have a pecuniary interest, and this report shall not be deemed an admission that they are the beneficial owners of these securities for purposes of Section 16. James Cavanaugh and Harold Werner are also directors of the Issuer.

Remarks:

	Jeffrey Steinberg, Administrative Partner	10/15/2003
	Jeffrey Steinberg, Administrative Partner	10/15/2003
	Jeffrey Steinberg, Attorney-in-Fact	10/15/2003
	Jeffrey Steinberg, Attorney-in-Fact	10/15/2003
	Jeffrey Steinberg, Attorney-in-Fact	10/15/2003
	Jeffrey Steinberg, Attorney-in-Fact	10/15/2003
	Jeffrey Steinberg, Attorney-in-Fact	10/15/2003
	Jeffrey Steinberg, Attorney-in-Fact	10/15/2003
	Jeffrey Steinberg, Attorney-in-Fact	10/15/2003
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.